Skip to main content

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Introduction

In an order issued on February 6, Arkansas federal Judge Timothy Brooks denied summary judgment request filed by Smith &  Nephew in a lawsuit involving its Synergy Stem artificial hip, finding questions of fact whether the hip system had a manufacturing and/ or compositional defect at the time it was implanted.

Judge Timothy Brooks refused to exclude the testimony provided by the plaintiff's expert witnesses and stated that the expert witnesses were qualified enough to have an opinion on metallurgy and damages. The plaintiff, John Myatt, underwent a hip replacement surgery in 2004, following a fatal car accident, and he was implanted with Smith & Nephew's Synergy Stem.

Smith & Nephew manufactures several hip replacement systems meant to increase mobility and improve durability. However, the company's metal-on-metal implants were linked to serious complications like metallosis. The company faces more than 500 hip implant lawsuits which are consolidated into federal litigation. Similar lawsuits are filed against other hip device manufacturers in the U.S. involving defendants Zimmer, Stryker, Biomet, Wright, and DePuy Synthes.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!